Clinical trial
AI-based Echocardiography for Detection of Cardiac Amyloidosis in Patients Undergoing Transthoracic Echocardiography With Left Ventricular Hypertrophy
NCT07529860 is registered in ClinicalTrials.gov with Germans Trias i Pujol Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AI-based Echocardiography for Detection of Cardiac Amyloidosis in Patients Undergoing Transthoracic Echocardiography With Left Ventricular Hypertrophy
- Lead sponsor
- Germans Trias i Pujol Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2026
- Completion date
- October 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac amyloidosis, heart failure with preserved ejection fraction (hfpef), left ventricular hypertrophy